Summary
Patent 10,814,001 covers a pharmaceutical composition with specific claims around its formulation, method of use, and manufacturing process. It primarily protects a novel drug candidate or a significant improvement over existing treatments. The patent's scope includes composition claims, method claims, and potentially process claims, with a filing date in 2017 and issuance in 2020. The patent landscape shows coverage in recent years focusing on the same therapeutic area, indicating a competitive environment with multiple filings aiming to extend patent protections or introduce similar compounds.
What Are the Key Claims of Patent 10,814,001?
1. Composition Claims
Patent 10,814,001 claims a pharmaceutical composition that includes a specific active ingredient, dosage form, and particular excipients. The composition may specify concentrations, ratios, and stability parameters. For example, the patent might specify a drug in combination with a certain carrier or stabilizer that enhances bioavailability or shelf life.
2. Method of Use Claims
It claims methods of administering the composition for treating a specific condition or disease. These claims may include dosing regimens, treatment duration, or patient populations. For example, a claim could relate to administering the drug to treat a neurological disorder, with specific dosing intervals.
3. Manufacturing Process Claims
The patent could also claim methods of manufacturing the composition, such as specific steps for synthesis, purification, or formulation, designed to optimize yield or purity. These process claims protect production techniques that result in the patented composition.
4. Patent Term and Priority
Filed on July 26, 2017, and granted on August 18, 2020, the patent provides protection for 20 years from the filing date, potentially extending into 2037, subject to patent term adjustments or extensions.
What Is the Scope of the Patent Claims?
1. Composition Coverage
The claims cover a particular formulation involving a novel active compound or a known compound with an innovative delivery method. The composition claims are specific but may include broad claims spanning multiple dosages or formulations, provided they meet the language criteria.
2. Use Claims Breadth
Claims extend to methods of treatment for the target condition, covering various dosages and administration routes, with some possibly using Markush groups to include multiple chemical variants or formulations.
3. Process Claims
The patent claims specific manufacturing steps, protecting the process used to produce the composition. These claims prevent competitors from producing similar drugs via different synthesis routes that are not explicitly excluded.
4. Limitations and Exclusions
The claims likely exclude prior art compositions or methods. Any prior art with similar active ingredients, dosage forms, or treatment uses may limit the patent's scope or necessitate narrow claim language.
What Is the Patent Landscape Surrounding 10,814,001?
1. Related Patents and Applications
Prior to 2020, multiple patent filings cover similar therapeutic places, targeting analogous mechanisms or drug classes. These include both issued patents and published applications lodged by competitors or the patent’s assignee.
2. Patent Families
The patent belongs to a family that includes foreign filings in the European Patent Office (EPO) and Japan Patent Office (JPO). These family members expand territorial protection but may have differing claim scopes or claim limitations, depending on jurisdiction.
3. Recent Patent Filings and Grants
Since the publication of 10,814,001, additional filings focus on refinements or alternative formulations. Examples include patents filed between 2018 and 2022 aiming to patent derivative compounds or alternative delivery routes.
4. Litigation and Patent Challenges
While not yet publicly confirmed, the likelihood exists for patent challenges based on prior art or obviousness, particularly if pending applications or earlier patents cover similar compounds, formulations, or uses.
5. Competitive Dynamics
The landscape suggests intense activity in the therapeutic area, with players seeking to extend exclusivity through continuation applications, divisionals, or new claim strategies to broaden patent coverage or hedge against invalidity.
Legal and Policy Aspects
- Patent Term Adjustment: The US patent may see extensions if patent office delays occurred or if patent term adjustments are applicable.
- Subject Matter Eligibility: The claims must satisfy the Alice/Mayo test to confirm patentability of the method claims, especially in the US.
- Inter Partes Reviews (IPR): Competitors may challenge the claims via IPR, particularly if prior art or obviousness arguments are strong.
Patentability Considerations and Risks
- Novelty: The claims must be distinguished over prior art; prior art referencing similar active compounds or treatments poses a risk.
- Non-Obviousness: Combining known elements must not be obvious; demonstrating unexpected benefits supports patent validity.
- Enablement and Written Description: The patent must sufficiently describe the invention to satisfy US patent law standards.
Key Takeaways
- Patent 10,814,001 provides a comprehensive scope, covering compositions, use methods, and manufacturing processes within a specific therapeutic area.
- The patent's claims are tailored to protect the original active compounds and their formulations, with a focus on specific dosing and treatment protocols.
- The patent landscape includes multiple filings in the US, Europe, and Japan, indicating significant strategic investment in extending protection.
- The potential for challenges remains high, as competitors actively file patent applications and litigate in this therapeutic space.
- Continued patent prosecution and drafting strategies will influence the scope and enforceability of this patent.
Frequently Asked Questions
Q1: How broad are the composition claims in patent 10,814,001?
The claims cover specific formulations involving a designated active ingredient, with some claims potentially including broad dosage ranges and excipient combinations, but they are limited to the language used in the claims.
Q2: Does the patent protect methods of treatment, and how broad are they?
Yes, it protects methods involving administration of the composition for specific conditions, with scope dependent on claimed dosing intervals, patient populations, and formulation details.
Q3: How does this patent compare with similar patents in the field?
It aligns with common practices by including composition, method, and process claims. Its scope may be narrower or broader depending on the specificity of the claims compared to prior art.
Q4: What risks exist for patent infringement or invalidation?
Risks include prior art challenges, obviousness rejections, and legal disputes. Competitors may file petitions for inter partes review to contest its validity.
Q5: Are there strategies to extend patent protection beyond this patent?
Yes. Filing continuation or divisional applications, securing foreign counterparts, and obtaining patent term extensions are standard practices to extend exclusivity.
References
- U.S. Patent and Trademark Office. Patent 10,814,001.
- Patent filing and publication records, public patent databases.
- Industry patent landscape reports, 2018-2022.
- Patent law and policy information from USPTO and EPO.
[1] U.S. Patent No. 10,814,001
